NCT02895958 is a Phase 4 clinical trial of Zepatier in Hepatitis C, sponsored by Mater Misericordiae University Hospital.

Who is sponsoring NCT02895958?

NCT02895958 is sponsored by Mater Misericordiae University Hospital.

What drugs are being tested in NCT02895958?

Interventions in NCT02895958: Zepatier.

What condition does NCT02895958 study?

NCT02895958 studies Hepatitis C.

Is NCT02895958 still recruiting?

NCT02895958 is currently terminated. Last updated 10 December 2019.

Last reviewed 2019-12-10 · How we verify

NCT02895958

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Dublin Zepatier Study

Terminated Phase 4 Last updated 10 December 2019

What this trial tests

Phase 4 trial testing Zepatier in Hepatitis C in 3 participants. Terminated before completion.

Timeline

15 March 2018

Primary endpoint
23 May 2019

6 December 2019

Quick facts

Lead sponsor	Mater Misericordiae University Hospital
Phase	Phase 4
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	3
Start date	15 March 2018
Primary completion	23 May 2019
Estimated completion	6 December 2019
Sites	1 location across Ireland

Drugs / interventions tested

Zepatier (GRAZOPREVIR) — full drug profile →

Conditions studied

Hepatitis C — all drugs for Hepatitis C →

Sponsor

Mater Misericordiae University Hospital

Who can join

18 and older, any sex, with Hepatitis C. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of Zepatier in a community-based setting among cirrhotic and non-cirrhotic patients on stable opiate substitution therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Zepatier

Trials testing the same drug.

NCT03791814 — A Prospective Cohort Study to Improve HCV Care in Dialysis Patients · Phase 4 · withdrawn
NCT03724149 — Transplanting Hepatitis C Lungs Into Negative Lung Recipients · Phase 1, PHASE2 · completed
NCT03093740 — Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transpl · Phase 4 · withdrawn
NCT03146741 — Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors ( · Phase 1, PHASE2 · completed
NCT02781649 — Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients · Phase 4 · completed

Other recruiting trials for Hepatitis C

Currently open trials in the same condition.

NCT06263829 — HCV Tappt Adherence Study · NA · recruiting
NCT06179498 — Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs · NA · recruiting
NCT06367465 — Feasibility and Acceptability of HCV Treatment in Pregnancy · recruiting
NCT05668780 — Buprenorphine Integration Research and Community Health · NA · active not recruiting
NCT05208697 — Tele-Harm Reduction · NA · active not recruiting

Other Mater Misericordiae University Hospital trials

Trials by the same sponsor.

NCT05642988 — Application of Wearable Technology in High-risk Surgical Patients in the Perioperative Period · completed
NCT05181371 — ESP Block in VATS: Programmed Intermittent Bolus Versus Continuous Infusion on Quality of Recovery · NA · completed
NCT04924010 — Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer Patients · NA · completed
NCT04729712 — Efficacy of Ultrasound Guided ESP Vs Video-assisted PVB Catheter Placement in Minimally Invasive Thoracic Surgery · NA · completed
NCT04370951 — Efficacy of the Erector Spinae Plane Block in Posterior Thoraco- Lumbar Spinal Decompression Surgery · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02895958 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mater Misericordiae University Hospital
Last refreshed: 10 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02895958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing